US · USD
VRTX
Vertex Pharmaceuticals Inc
- Day's range
- $522.74 – $529.72
- Day's volume
- $575.5M
- 52-week range
- $402.90 – $557.96
Follow VRTX in the Fuolio
See how VRTX weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountVRTX in numbers
- Market cap
- $132.5B
- P/E
- 29.48
- P/B
- 6.41
- Dividend yield (12m)
- 0.00%
VRTX trades at 29.48 times its earnings of the last 12 months.
VRTX price history
VRTX risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +33.38% | +50.22% | +187.99% |
| Volatility (annualized) | 24.64% | 26.69% | 25.57% |
| Largest drawdown | -13.98% | -23.25% | -23.25% |
| Positive months | 8/12 | 23/36 | 39/60 |
How much did investing in VRTX return?
$1,000.00 invested on 10/01/2021 would be worth $2,770.32 today.
- Value today in VRTX
- $2,770.32
- Return over the period
- +177.03%
- Return per year
- +22.61%
- In the S&P 500
- $1,659.94
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
VRTX fundamentals
Valuation
- P/E29.48
- P/B6.41
- EV/EBITDA26.51
- EV/EBIT27.74
- EV/Revenue10.53
- P/EBIT27.74
- P/S10.53
- P/OCF30.87
- P/FCF34.91
- Earnings yield3.61%
- PEG ratio—
- Earnings per share$17.38
- Book value per share$79.89
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio3.19
- Quick ratio2.74
- Cash ratio1.99
Efficiency
- Gross margin86.00%
- EBITDA margin39.72%
- Operating margin37.95%
- Net margin35.00%
- Asset turnover0.46
Profitability
- ROE21.76%
- ROA16.06%
- ROIC19.70%
- Payout0.00%
Growth
- Revenue CAGR (5 years)13.50%
- Earnings CAGR (5 years)17.21%
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
What is VRTX's fair price?
Two classic value formulas, with today's numbers. The current price is $512.32.
- Graham's fair price
- $176.75
- 65.50% below the price
√(22.50 × $17.38 × $79.89)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- —
- Does not apply to VRTX: it paid no distributions in the last five years.
Décio Bazin only bought stocks yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years over 6%.
Graham ignores growth and debt; Bazin assumes past distributions repeat. They are references to compare, not a buy recommendation.
VRTX's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 29.13 | -193.07 | 29.04 | 22.35 | 23.87 | 22.66 | 48.24 | 20.20 |
| P/B | 6.17 | 6.30 | 5.98 | 5.34 | 5.54 | 7.07 | 9.33 | 9.55 |
| EV/EBITDA | 26.28 | — | 26.19 | 16.66 | 19.23 | 20.72 | 43.52 | 59.87 |
| Earnings per share | $15.56 | -$2.09 | $14.01 | $12.92 | $9.20 | $10.43 | $4.54 | $8.20 |
| Book value per share | $73.48 | $63.90 | $68.06 | $54.12 | $39.67 | $33.42 | $23.47 | $17.35 |
| ROE | 21.18% | -3.26% | 20.59% | 23.88% | 23.19% | 31.22% | 19.34% | 47.28% |
| ROIC | 19.04% | 0.00% | 18.01% | 24.30% | 23.63% | 28.61% | 16.60% | 14.32% |
| Gross margin | 86.24% | 86.11% | 87.21% | 87.90% | 88.06% | 88.14% | 86.84% | 86.56% |
| EBITDA margin | 36.52% | -0.23% | 40.66% | 49.89% | 38.39% | 47.79% | 31.33% | 23.22% |
| Net margin | 32.94% | -4.86% | 36.68% | 37.20% | 30.92% | 43.70% | 28.27% | 68.80% |
VRTX's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $12B | $11B | $9.9B | $8.9B | $7.6B | $6.2B |
| Cost of revenue | -$1.7B | -$1.5B | -$1.3B | -$1.1B | -$904.2M | -$736.3M |
| Gross profit | $10.4B | $9.5B | $8.6B | $7.9B | $6.7B | $5.5B |
| EBITDA | $4.4B | -$25.7M | $4B | $4.5B | $2.9B | $3B |
| EBIT | $4.2B | -$232.9M | $3.8B | $4.3B | $2.8B | $2.9B |
| Financial result | — | — | — | — | — | — |
| Income before tax | $4.6B | $248.5M | $4.4B | $4.2B | $2.7B | $3.1B |
| Income tax | -$690M | -$784.1M | -$760.2M | -$910.4M | -$388.3M | -$405.2M |
| Net income | $4B | -$535.6M | $3.6B | $3.3B | $2.3B | $2.7B |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does VRTX pay dividends?
VRTX has no distributions on record.
About Vertex Pharmaceuticals
- Sector
- Manufacturing
Questions about VRTX
How much is VRTX today?
VRTX is at $512.32 (-2.74% on the day), last traded on 10/01/2026.
What are the P/E and P/B of VRTX?
VRTX trades at a P/E of 29.48 and a P/B of 6.41.
How much did VRTX return in 12 months?
VRTX returned 33.38% in 12 months, with annualized volatility of 24.64% and a largest drawdown of -13.98%.